02:48 AM EST, 03/06/2025 (MT Newswires) -- Jonathan Young, Chief Operating Officer, on March 04, 2025, sold 50,000 shares in Akero Therapeutics ( AKRO ) for $2,243,213. Following the Form 4 filing with the SEC, Young has control over a total of 261,147 common shares of the company, with 201,147 shares held directly and 60,000 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1744659/000095017025033998/xslF345X05/ownership.xml